1.9k
France: tier 3, and what it actually costs here
Right, the private prescription question again, but with numbers this time. I have 24 data points over 12 weeks. The pattern is consistent enough that I do not think it…
u/milos_mensa
Contributes reviews on supplier material. Based in Nairobi.
member · joined 12 Mar 2025
3,357post karma
3,490comment karma
5submissions
69comments
Overview — page 3 of 4
comment on anyone else notice dual agonist kicking in around week 80 in c/survodutide · 304 points · 11 months ago
the GLP-1/glucagon dual is dual agonist, different from GIP/GLP-1
comment on [Question] Ireland — has anyone got a straight answer on API source in c/compounding · 37 points · 1 year ago
What is the actual shortage list status right now?
comment on [Question] tracking — what am I missing here in c/dosinglogs · 1 points · 1 year ago
[removed by moderator]
Disagree on that part. 95.1% and 98.3% on the same vial is normal.
comment on pricing: the version I wish someone had shown me in week 1 in c/glp1uk · 71 points · 1 year ago
NHS or private?
comment on pricing: the version I wish someone had shown me in week 1 in c/glp1uk · 273 points · 1 year ago
England or Scotland? Different pathways.
comment on [Question] Ireland — has anyone got a straight answer on import in c/customs · 7 points · 1 year ago
personal-import allowances differ by country
comment on [Discussion] we are measuring customs at the wrong time and calling it noise in c/customs · 7 points · 1 year ago
no advice on evading inspection or misdeclaring
comment on three years of biopsy threads, summarised so you do not have to read them in c/survodutide · 34 points · 1 year ago
The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.
comment on why does nobody talk about pricing in c/glp1uk · 19 points · 1 year ago
the tier 3 pathway is the only free route, it is slow
comment on compounding — 17 things I got wrong before I got it right in c/compounding · 28 points · 1 year ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on NHS vs UK — genuinely asking which matters more in c/glp1uk · 9 points · 1 year ago
Yeah, the NHS waitlist is genuinely two years in most places.
comment on NHS vs UK — genuinely asking which matters more in c/glp1uk · 20 points · 1 year ago
Small correction: the trial was 20 weeks, not 10. Does not change your point but people will quote it.
comment on what would you tell week-1 you about compounding in c/compounding · 39 points · 1 year ago
telehealth prescriber models exist, pricing differs by state
comment on what would you tell week-1 you about import in c/customs · 22 points · 1 year ago
the personal import status depends on what happens at the border
comment on [Results] 52 weeks, 25kg, and dual agonist was the hard part in c/survodutide · 46 points · 1 year ago
do not generalise from tirzepatide
comment on 6 months in and shortage list is still the thing I get wrong in c/compounding · 15 points · 1 year ago
the shortage list is temporary, it ends and compounding becomes illegal again
comment on the Netherlands: seizure, and what it actually costs here in c/customs · 16 points · 1 year ago
This is an urgent-care question wearing a forum question's clothes.
Disagree on that part. 97.6% and 97.9% on the same vial is normal.
comment on [Discussion] we are measuring 503B at the wrong time and calling it noise in c/compounding · 19 points · 1 year ago
telehealth prescriber models exist, pricing differs by state
comment on three years of 503A threads, summarised so you do not have to read them in c/compounding · 74 points · 1 year ago
Did they tell you their API source or dodge the question?